CHEARS News Room
This is News Broadcast Room of CHEARS.
Our purpose is to create awareness among general public through the various health news updates and interventional updates from the sector of healthcare. This News Room works under Dr. Keerthana Ramesh, Chief Editor, Department of CNAR, CHEAARS.
Warning to Website Operators Illegally Selling Opioids
19 September 2020
he U.S. Food and Drug Administration has issued warning letters to 17 website operators for illegally selling unapproved and misbranded opioids online in violation of the Federal Food, Drug, and Cosmetic Act. Misbranded opioids include those offered for sale without a prescription, as well as opioids that lack adequate directions for use.
The opioids offered for sale include products such as tramadol and oxycodone. These are prescription drugs that have significant risks of addiction, abuse and misuse, which can lead to overdose and death, and should only be used under the supervision of a licensed health care provider. These warning letters are a continuation of the FDA’s commitment to take action against the illegal sale of opioids over the internet.
The warning letters were issued to:
alpharoyalpharmacy.com
beststeroidstore.net
bluepillmedications.com
buydrugsmedsonline.com
genericpharmacyusa.com
globalpharmacystores.com
greenrxpharmacy.com
klasiekpharmacy.com
lekapharma.com
mega-pillspharmacy.com
melanopharmacy.com
roidsforce.com
rxeasymeds.com
skylimitpharmacy.com
Thomas Meds
uspharmacyshop.com
xsteroids.com
In addition to the significant risks of addiction, abuse and misuse, opioids can cause life-threatening respiratory depression (breathing problems), which can lead to overdose and death, and withdrawal symptoms in newborn babies. When taken with other central nervous system depressants, including alcohol, the use of opioids may result in coma or death.
14
It will be great, if you share your view on above write-up.
Your content has been submitted. Please refresh page to see comment